These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Adverse drug effects and pegylation. Wooten JM South Med J; 2011 Feb; 104(2):83-4. PubMed ID: 21206333 [No Abstract] [Full Text] [Related]
31. Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin. Antonini MG; Babudieri S; Maida I; Baiguera C; Zanini B; Fenu L; Dettori G; Manno D; Mura MS; Carosi G; Puoti M Infection; 2008 Jun; 36(3):250-5. PubMed ID: 18458815 [TBL] [Abstract][Full Text] [Related]
32. Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data. Cammà C; Di Bona D; Schepis F; Heathcote EJ; Zeuzem S; Pockros PJ; Marcellin P; Balart L; Alberti A; Craxì A Hepatology; 2004 Feb; 39(2):333-42. PubMed ID: 14767986 [TBL] [Abstract][Full Text] [Related]
33. Viral kinetics in genotype 1 chronic hepatitis C patients during therapy with 2 different doses of peginterferon alfa-2b plus ribavirin. Buti M; Sanchez-Avila F; Lurie Y; Stalgis C; Valdés A; Martell M; Esteban R Hepatology; 2002 Apr; 35(4):930-6. PubMed ID: 11915041 [TBL] [Abstract][Full Text] [Related]
34. Follow-up of adverse drug reactions from peginterferon alfa-2b-ribavirin therapy. Bagheri H; Fouladi A; Barange K; Lapeyre-Mestre M; Payen JL; Montastruc JL; Vinel JP Pharmacotherapy; 2004 Nov; 24(11):1546-53. PubMed ID: 15537560 [TBL] [Abstract][Full Text] [Related]
35. [PEG-interferon alfa 2a against hepatitis C. Better as the standard therapy]. MMW Fortschr Med; 2001 Nov; 143(44):58. PubMed ID: 11732405 [No Abstract] [Full Text] [Related]
36. A rare complication of pegylated interferon Alfa 2a in a hepatitis C-positive patient on maintenance hemodialysis. Satish R; ; Mathew T Saudi J Kidney Dis Transpl; 2012 Jan; 23(1):139-42. PubMed ID: 22237239 [No Abstract] [Full Text] [Related]
37. [New perspectives in the treatment of viral hepatitis C: pegylated interferon alpha]. Alric L; Cacoub P Rev Med Interne; 2001 Oct; 22(10):922-5. PubMed ID: 11695314 [No Abstract] [Full Text] [Related]
38. [Sarcoidosis associated with the treatment of hepatitis C: case report and Spanish literature review]. Trullàs JC; Hernández-Marcet P; Bisbe J Med Clin (Barc); 2011 May; 136(14):649-50. PubMed ID: 21051060 [No Abstract] [Full Text] [Related]
39. Predicting sustained virological response and anaemia in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) plus ribavirin. Snoeck E; Wade JR; Duff F; Lamb M; Jorga K Br J Clin Pharmacol; 2006 Dec; 62(6):699-709. PubMed ID: 17118125 [TBL] [Abstract][Full Text] [Related]
40. Interferon for hepatitis C patients with psychiatric disorders. Asnis GM; De La Garza R; Rego SA; Henderson MA; Reinus JF Am J Psychiatry; 2004 Dec; 161(12):2332; author reply 2332-4. PubMed ID: 15569920 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]